Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
391
days
Precision oncology in advanced melanoma: molecular landscapes and personalized therapy recommendations from the Molecular Tumor Board Freiburg
Authors
T. Lowinus; V. Schipperges; P. Metzger; T. Brummer; U. Matysiak; E. P. Dopfer; M. E. Hess; M. Fahrner; T. Pauli; A. Blaumeiser; H. Becker; J. Kuehn; M. Rassner; J. Falkenstein; H. Bertemes; P. Bovio; N. Pinter; S. Cysar; S. Lehr; R. Wäsch; L. Gräßel; K. Eyerich; A. M. Schultheis; O. Schilling; S. Lassmann; M. Werner; A. L. Illert; J. Duyster; R. Zeiser; C. C. Miething; M. Boerries; F. Meiss; D. RafeiShow moreShow less
Affiliations
1. Department of Medicine I—Medical Centre—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 2. Comprehensive Cancer Center Freiburg, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 3. Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 4. German Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between DKFZ and Medical Center—University of Freiburg, Freiburg, Germany; 5. Institute of Molecular Medicine and Cell Research (IMMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany; 6. Institute for Surgical Pathology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 7. Department of Dermatology and Venereology—Medical Centre—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 8. Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany; 9. Department of Medicine III, Faculty of Medicine, Klinikum Rechts der Isar, Technical University Munich (TUM), Munich, Germany; 10. Center of Personalized Medicine, Technical University of Munich (TUM), University Hospital, Technical University of Munich, Munich, GermanyShow moreShow less
342
days
Machine learning uncovers previously undetectable genetic deletions in cancer panel sequencing
Authors
Irina A. Kerle; Oleksandr Husak; Thomas Gross; Andreas Hartig; Rebecca Prause; Daniela Richter; Sascha Brückmann; Maximilian Werner; Anja Kögler; Dorothea Hanf; Lino Möhrmann; Doreen William; Karsten Wendt; Nicole Pfarr; Carolin Mogler; Daniela E. Aust; Evelin Schröck; Christoph Heining; Hanno GlimmShow moreShow less
Affiliations
1. Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; 2. Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 3. German Cancer Consortium (DKTK), partner site Dresden, a partnership between DKFZ and University Hospital Carl Gustav Carus Dresden, Dresden, Germany; 4. Chair of Software Technology, Faculty of Computer Science, Technical University Dresden, Dresden, Germany; 5. Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 6. Institute of Pathology, Carl Gustav Carus University Hospital, Dresden, Germany; 7. Department of Internal Medicine I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 8. Computational Health Informatics Program, Boston Children’s Hospital, Harvard Medical School, Boston, USA; 9. Internal Medicine C, Hematology, Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald, Greifswald, Germany; 10. Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany; 11. ERN GEN-TURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; 12. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; German Cancer Consortium (DKTK), partner site: Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 13. Institute of Pathology, School of Medicine and Health, Technical University Munich, Munich, GermanyShow moreShow less
100
days
Multi-omics profiling identifies triciribine as a biomarker-guided antimetabolite therapy for acute lymphoblastic leukemia
Authors
Xuekang Qi; Georgios Mermelekas; Ondrej Hodek; Luay Aswad; Quentin Glaziou; Isabelle Rose Leo; Nona Struyf; Femke M. Hormann; Ioannis Siavelis; Henri Colyn Bwanika; Owen F. J. Hovey; Martin Haraldsson; Sean G. Rudd; Annika I. Johansson; Tom Erkers; Katja Pokrovskaja Tamm; Janne Lehtiö; Rozbeh JafariShow moreShow less
Affiliations
1. Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden; 2. Swedish Metabolomics Centre, Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, Umeå, Sweden; 3. Molecular Precision Medicine, Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden; 4. Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden; 5. Department of Oncology-Pathology, Karolinska Institutet, J6:140 BioClinicum, Solna, Sweden; 6. Chemical Biology Consortium Sweden, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; 7. Swedish Metabolomics Centre, Department of Plant Physiology, Umeå University, Umeå, SwedenShow moreShow less
107
days
Skill-guided agentic reasoning enables longitudinal synthesis of myeloma records at expert-level concordance
Authors
Johannes Moll; Jannik Lübberstedt; Christoph Nuernbergk; Jacob Stroh; Luisa Mertens; Anna Purcarea; Christopher Zirn; Zeineb Benchaaben; Fabian Drexel; Hartmut Häntze; Anirudh Narayanan; Friedrich Puttkammer; Andrei Zhukov; Jacqueline Lammert; Sebastian Ziegelmayer; Markus Graf; Marion Högner; Marcus Makowski; Florian Bassermann; Lisa C. Adams; Jiazhen Pan; Daniel Rueckert; Krischan Braitsch; Keno K. BressemShow moreShow less
Affiliations
1. Chair for AI in Healthcare and Medicine, Technical University of Munich (TUM) and TUM University Hospital, Munich, Germany; 2. Technical University of Munich, School of Medicine and Health, TUM University Hospital, Klinikum rechts der Isar, Department of Diagnostic and Interventional Radiology, Munich, Germany; 3. Technical University of Munich, School of Medicine and Health, TUM University Hospital, German Heart Center, Department of Cardiovascular Radiology and Nuclear Medicine, Munich, Germany; 4. Technical University of Munich, School of Medicine and Health, TUM University Hospital, Klinikum rechts der Isar, Department of Medicine III, Munich, Germany; 5. Department of Radiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; 6. Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; 7. Chair of Medical Informatics, Institute of Artificial Intelligence in Medicine and Healthcare, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany; 8. Clinical Department of Gynecology, TUM University Hospital, TUM School of Medicine and Health, Munich, Germany; 9. TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany; 10. Deutsches Konsortium für Translationale Krebsforschung, Heidelberg, Germany; 11. Bavarian Cancer Research Center, Munich, Germany; 12. Department of Engineering Science, University of Oxford, Oxford, UK; 13. Munich Center for Machine Learning (MCML), Munich, Germany; 14. Department of Computing, Imperial College London, London, UK; 15. National Center for Tumor Diseases West, Essen, Germany; 16. Institute of Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany; 17. Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, GermanyShow moreShow less
216
days
Minigene-based characterization and classification of splice-associated variants in succinate dehydrogenase B
Authors
Anni Köhler; Alexandra A. Baumann; Natasha Lewis; Anja Richter; Susan Richter; Doreen William; Andrés Cruz-García; Hanno Glimm; Stefan Fröhling; Diana Le Duc; Evelin Schröck; Arne JahnShow moreShow less
Affiliations
1. Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany; 2. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 3. ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; 4. DKTK, Partner Site Dresden, Dresden, Germany; 5. Department of Systems Biology and Bioinformatics, University of Rostock, Rostock, Germany; 6. Institute for Medical Informatics and Biometry, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 7. Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand; 8. Core Unit for Molecular Tumor Diagnostics (CMTD), NCT/UCC Dresden, a Partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 9. Department for Translational Medical Oncology, National Center for Tumor Diseases (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 10. Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 11. Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 12. National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; 13. German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; 14. Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, GermanyShow moreShow less
248
days
A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions
Authors
Julius Thyen; Victor A. Sioson; Daniel Haak; Beatrix Jahnke; Maximilian Fusenig; Abdul M. Aftab; Antonia Stammberger; Sascha Brückmann; Heike Polster; Stefanie Hübner; Verena J. Kast; Manuel Pfeifer; Rebecca Prause; Vivian Mittné; Carolin Beer; Malin H. Reinhart; Adrian M. Seifert; Lena Seifert; Martin Bornhäuser; Carsten Werner; Marc Schmitz; Daniela E. Aust; Jürgen Weitz; Daniela Loessner; Daniel E. Stange; Anna R. Poetsch; Mathieu Pecqueux; Franziska BaenkeShow moreShow less
Affiliations
1. Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 2. Leibniz Institute of Polymer Research Dresden, Max Bergmann Center of Biomaterials, Dresden, Germany; 3. Biomedical Genomics, Biotechnology Center, Center for Molecular and Cellular Bioengineering, TUD Dresden University of Technology, Dresden, Germany; 4. Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 5. Institute of Pathology and Tumor- and Normal Tissue Bank of the University Cancer Center (UCC), University Hospital Carl Gustav Carus, Medical Faculty, TUD Dresden University of Technology, Dresden, Germany; 6. Institute of Legal Medicine, Medizinische Fakultät, TUD Dresden University of Technology, Dresden, Germany; 7. Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases Dresden (NCT/UCC), Dresden, Germany; 8. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 9. German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 10. Else Kröner Clinician Scientist Professor for Translational Tumor Immunological Research, TUD Dresden University of Technology, Dresden, Germany; 11. Medical Clinic I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 12. Center for Regenerative Therapies Dresden (CRTD) and Cluster of Excellence Physics of Life (PoL), TUD Dresden University of Technology, Dresden, Germany; 13. Department of Chemical and Biological Engineering and Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Melbourne, Australia; 14. Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; 15. Institute for Genetics, University of Cologne, Cologne, Germany; 16. Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; 17. Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, GermanyShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
